Synthesize Bio

Seattle, Washington, United States

Synthesize Bio is a healthcare startup focusing on generative genomics to predict outcomes of gene expression experiments using AI. The company provides AI-enriched metadata and expression profiles to support biomarker-driven clinical trial design and real-world evidence generation. Their platform accelerates clinical biomarker discovery, enhances clinical trial optimization, and supports precision medicine insights through harmonized expression data. Additionally, they offer pharmacodynamic modeling and synthetic RNA-seq data for mechanism of action studies. By leveraging large-scale omics and customizable AI models, Synthesize Bio aids in identifying novel therapeutic targets and predicting therapeutic responses, ultimately streamlining drug development processes for biopharma partners.